Risk factors
Vir Biotechnology (VIR) risk factors
Item 1A of every Vir Biotechnology, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors50 risks4 dropped23 reworded
Net operating loss carryforwards rose to $1.2 billion federally, while the accumulated deficit reached $1.2 billion.
Filed Feb 23, 2026 - FY2024 10-K risk factors54 risks
Clinical stage biotechnology company developing treatments for infectious diseases and other serious conditions with ongoing net losses.
Filed Feb 27, 2025